New Zealand markets open in 14 minutes

Sonoma Pharmaceuticals, Inc. (SNOA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.6121+0.0221 (+0.62%)
As of 03:43PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 14.93M
Enterprise value 8.02M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.71
Price/book (mrq)1.30
Enterprise value/revenue 0.55
Enterprise value/EBITDA -1.59

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 3-59.62%
S&P500 52-week change 314.85%
52-week high 313.3600
52-week low 33.2800
50-day moving average 34.7612
200-day moving average 36.1832

Share statistics

Avg vol (3-month) 3196.81k
Avg vol (10-day) 384.01k
Shares outstanding 53.1M
Implied shares outstanding 6N/A
Float 83.08M
% held by insiders 10.63%
% held by institutions 16.84%
Shares short (30 Dec 2021) 4102.91k
Short ratio (30 Dec 2021) 41.31
Short % of float (30 Dec 2021) 43.34%
Short % of shares outstanding (30 Dec 2021) 43.32%
Shares short (prior month 29 Nov 2021) 4176.78k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 319 Jun 2019
Ex-dividend date 4N/A
Last split factor 21:9
Last split date 319 Jun 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Mar 2021
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin -37.93%
Operating margin (ttm)-33.21%

Management effectiveness

Return on assets (ttm)-15.87%
Return on equity (ttm)-45.66%

Income statement

Revenue (ttm)14.52M
Revenue per share (ttm)6.77
Quarterly revenue growth (yoy)-35.10%
Gross profit (ttm)6.56M
EBITDA -4.6M
Net income avi to common (ttm)-5.26M
Diluted EPS (ttm)-2.5700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.39M
Total cash per share (mrq)2.71
Total debt (mrq)1.49M
Total debt/equity (mrq)12.97
Current ratio (mrq)4.42
Book value per share (mrq)3.81

Cash flow statement

Operating cash flow (ttm)-3.26M
Levered free cash flow (ttm)-1.7M